Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma [Phase 3]

View source ↗

Summary

DW1807 is being studied in a Phase 3 trial for perennial allergic rhinitis with asthma, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Perennial Allergic Rhinitis

Drugs mentioned

• DW1807

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Perennial Allergic Rhinitis Accompanied by Asthma | Phase 3 | Status: RECRUITING